By now you may have heard the latest news on the fight to end Alzheimer’s disease. The Food and Drug Administration (FDA) has approved a new drug, developed by Biogen, called Aducanumab to potentially delay the cognitive decline experienced in Alzheimer’s disease. This is exciting news because, prior to this, medications have focused only […]
